ArticleBritish journal of cancer2024

PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway.

Haibo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.